Effects of mineralocorticoid receptor antagonists in patients with preserved ejection fraction: a meta-analysis of randomized clinical trials

BACKGROUND: Mineralocorticoid receptor antagonists (MRAs) have been shown to be effective in patients with heart failure or myocardial infarction complicated by a reduced ejection fraction. However, the role of MRAs in patients with preserved ejection fraction (PEF) remains to be clarified. We aimed...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yanmei, Wang, He, Lu, Yongkang, Huang, Xiaobo, Liao, Yulin, Bin, Jianping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4307751/
https://www.ncbi.nlm.nih.gov/pubmed/25598008
http://dx.doi.org/10.1186/s12916-014-0261-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4307751/
https://www.ncbi.nlm.nih.gov/pubmed/25598008
http://dx.doi.org/10.1186/s12916-014-0261-8

Ejemplares similares